A Tube Feeding Study in Malnourished Population With Diabetes

Clinical Trial Summary

This is a prospective, non-interventional, observational study. Malnourished subjects with diabetes, who are receiving a high calorie, high protein tube feeding with slow release carbohydrates and MUFA by their health care professional (HCP) per standard of care will be enrolled into the study.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03802942` - Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care	Phase 3
Completed	`NCT02987335` - Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
Recruiting	`NCT05291351` - Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT03802942 - Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care

Phase 3

Completed

NCT02987335 - Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States

Recruiting

NCT05291351 - Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03766620
Study type	Observational
Source	Abbott Nutrition
Contact
Status	Completed
Phase
Start date	November 29, 2018
Completion date	July 1, 2020

A Tube Feeding Study in Malnourished Population With Diabetes

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms